Last updated on October 2017

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan


Contact Investigators or Research Sites near you

Start Over

For site information, send an ...

Investigational Site Number 392136
Kamogawa-Shi, Japan
  Connect »